登录 | 注册    关注公众号  
微信公众号
搜索
 > 【SMN1】

SMN1信息

英文名称:Survival motor neuron protein
中文名称:运动神经元存活蛋白
靶点别称:Survival Of Motor Neuron 1 Isoform D345,Survival Of Motor Neuron 1 Isoform D2A2B3457,Survival Of Motor Neuron 1 Isoform D347,SMN1 more,SMN1,Survival Of Motor Neuron 1 Isoform D3457,Survival Of Motor Neuron 1, Telomeric,Gemin-1,Tudor Domain Containing 16A,SMNT,SMN,Survival Motor Neuron 1 Protein,Survival Motor Neuron Protein,T-BCD541,TDRD16A,BCD541,GEMIN1,SMA1,SMA2,SMA3,SMA4,SMA@,SMA,SMN Complex Proteins,Component of gems 1,SMN2,SMNC,Survival Of Motor Neuron 1 Isoform D2B3457,Survival Of Motor Ne
上市药物数量:3
临床药物数量:6
最高研发阶段:批准上市

SMN1产品列表

产品库
物种
标签
属性
货号 物种 产品描述 蛋白结构 纯度 活性
SM1-H5145
Human
Human SMN1 Protein, His Tag
ACRO质量管理体系
 
评论(0)
 

SMN1分子别名

Survival Motor Neuron 1,SMN1

SMN1分子背景

SMN1 is produced chiefly by the SMN1 gene, located on the telomeric portion of chromosome 5q. SMN1 protein is one of a group of proteins called the SMN complex, which is important for the maintenance of specialized nerve cells called motor neurons. In cells, the SMN complex plays an important role in processing mRNA. The SMN complex helps to assemble the cellular machinery needed to process pre-mRNA. The SMN complex is also important for the development of specialized outgrowths from nerve cells called dendrites and axons. Deletion or mutation of the SMN1 gene results in a reduced level of full-length SMN protein and manifests as a range of neuromuscular phenotypes in humans as the disease spinal muscular atrophy (SMA).

SMN1上市药物信息

英文名称 中文名称 研发代码 研发阶段 公司 最早商品名 最早批准国家 最早适应症 最早批准公司 最早批准日期 适应症 临床试验
Risdiplam 利司扑兰 RG-7916; RO-7034067 批准上市 Ptc Therapeutics Inc EVRYSDI, 艾满欣 United States 脊髓性肌萎缩 Genentech Inc 2020-08-07 脊髓性肌萎缩 详情
Nusinersen sodium 诺西那生钠 BIIB-058; ISIS-396443 批准上市 Ionis Pharmaceuticals Inc, 百健 Spinraza United States 脊髓性肌萎缩 Biogen Idec 2016-12-23 脊髓性肌萎缩 详情
Onasemnogene abeparvovec rAAV-9; AVXS-101; scAAV-9.CB.SMN; OAV101 批准上市 Novartis Gene Therapies Inc, 诺华制药 Zolgensma United States 脊髓性肌萎缩 Novartis Gene Therapies Inc 2019-05-24 小儿脊髓性肌萎缩, 脊髓性肌萎缩 详情

SMN1临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
Branaplam LMI-070; NVS-SM1 临床二期 诺华制药 亨廷顿舞蹈症, 脊髓性肌萎缩 详情
vesemnogene lantuparvovec (Lantu Biopharma) AAV-hSMN1 临床二期 Lantu Biopharma Inc 脊髓性肌萎缩 详情
EXG001-307 EXG001-307 临床二期 杭州嘉因生物科技有限公司 脊髓性肌萎缩 详情
SMN-C3 SMN-C3 临床一期 Ptc Therapeutics Inc, 罗氏 脊髓性肌萎缩 详情
SKG-0201 SKG0201; SKG-0201 临床一期 Skyline Therapeutics (Hong Kong) Ltd 小儿脊髓性肌萎缩, 脊髓性肌萎缩 详情
BIIB-115 BIIB-115; ION-306 临床一期 Ionis Pharmaceuticals Inc 脊髓性肌萎缩 详情

消息提示

请输入您的联系方式,再点击提交!

确定